Literature DB >> 8111278

Early treatment of Parkinson's disease. Open studies are unreliable.

V Myllylä, E Heinonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8111278      PMCID： PMC2539316          DOI： 10.1136/bmj.308.6923.272a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Selegiline and levodopa in early or moderately advanced Parkinson's disease: a double-blind controlled short- and long-term study.

Authors:  B Sivertsen; E Dupont; B Mikkelsen; P Mogensen; C Rasmussen; F Boesen; E Heinonen
Journal:  Acta Neurol Scand Suppl       Date:  1989

2.  Selegiline in de novo parkinsonian patients: the Finnish study.

Authors:  V V Myllylä; K A Sotaniemi; J A Vuorinen; E H Heinonen
Journal:  Mov Disord       Date:  1993       Impact factor: 10.338
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.